既往人工关节感染史患者初次全关节置换术后假体周围感染发生率与危险因素
该回顾性队列研究分析2010至2023年因另一关节既往手术治疗假体周围感染(PJI)后行初次全髋或全膝关节置换的患者,1年PJI发生率为1.5%,与对照组相比无显著差异(P=0.25);既往一或二期翻修者风险为2.2%,既往清创保留假体者为0。
要点
- 既往PJI史患者行初次TJA后1年PJI发生率为1.5%,与对照相比无显著升高(P=0.25)。
- 既往一或二期翻修者PJI风险为2.2%,清创保留假体者为0。
- 既往PJI史患者合并症负担更重,McPherson B/C型宿主比例显著更高(P<0.0001)。
核心结论
- 有PJI史患者在另一关节行初次TJA时合并症负担高于对照,但经适当优化后1年感染风险低,与对照相当。
研究设计与样本
- 回顾性二次分析,纳入2010至2023年机构数据库中因另一髋或膝关节既往PJI经清创保留假体或一/二期翻修治疗后行初次全髋或全膝关节置换的患者。
主要发现
- 初次TJA后1年PJI发生率为1.5%,与对照相比无更高风险(P=0.25)。
- 既往一或二期翻修者PJI发生率为2.2%,既往清创保留假体者为0。
- 既往PJI史患者McPherson B型和C型宿主比例显著高于对照(P<0.0001)。
- 多微生物感染最常见。
关键数值与推荐
- 1年PJI发生率:总体1.5%,既往一/二期翻修者2.2%,既往清创保留假体者0。
- 与对照比较P=0.25;McPherson分型比较P<0.0001。
临床怎么用
- 对既往PJI史患者行初次TJA前应积极内科优化,以最大化预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients who have a history of treated periprosthetic joint infection (PJI) in total joint arthroplasty (TJA) may represent a high-risk population for repeat PJI when undergoing another primary TJA. The purpose of this study was to determine the incidence of PJI following primary total hip or knee arthroplasty in patients who had a history of surgically treated PJI in another joint and to identify risk factors associated with subsequent infection. METHODS: We performed a retrospective secondary analysis of patients who underwent primary total hip or knee arthroplasty after prior treatment of PJI in another hip or knee joint with debridement, antibiotics, and implant retention, or one- or two-stage revision. Patients were identified from an institutional database between 2010 and 2023. The primary outcome was subsequent PJI, evaluated by the treatment strategy and patient factors. Demographics, comorbidities, surgical variables, microbiology, and timing between procedures were collected. RESULTS: The incidence of PJI after 1 year in primary TJA in patients who had a history of treated PJI was 1.5%. We did not observe a higher risk of PJI in comparison with the control cohort (P = 0.25). Those treated with one- or two-stage exchange were at higher risk (2.2%) versus prior treatment with debridement, antibiotics, and implant retention (zero). Patients who had a history of PJI had a higher comorbidity burden than controls, with a significantly greater proportion of McPherson Type B and C hosts (P < 0.0001). Polymicrobial infections were the most common. CONCLUSIONS: Patients who had a history of PJI undergoing subsequent primary TJA in another joint have a higher comorbidity burden than control TJA patients. Nevertheless, when appropriately optimized, they can safely undergo TJA with a low infection risk comparable to that of controls at one year. Medical optimization should be pursued to maximize outcomes in these challenging patients.
引用
- Constantinescu DS, Graham SD, Dombrowsky A, et al. Incidence and Risk Factors for Periprosthetic Joint Infection in Patients Undergoing Primary Total Joint Arthroplasty Who Have a History of Surgically Treated Periprosthetic Joint Infection in Another Joint. J Arthroplasty. 2026. PMID: 42637023. doi:10.1016/j.arth.2026.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。